These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788 [TBL] [Abstract][Full Text] [Related]
11. The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants. Wong SS; Duan S; DeBeauchamp J; Zanin M; Kercher L; Sonnberg S; Fabrizio T; Jeevan T; Crumpton JC; Oshansky C; Sun Y; Tang L; Thomas P; Webby R Sci Rep; 2017 Mar; 7():44727. PubMed ID: 28303960 [TBL] [Abstract][Full Text] [Related]
12. Animal models in influenza vaccine testing. van der Laan JW; Herberts C; Lambkin-Williams R; Boyers A; Mann AJ; Oxford J Expert Rev Vaccines; 2008 Aug; 7(6):783-93. PubMed ID: 18665776 [TBL] [Abstract][Full Text] [Related]
13. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Lu X; Edwards LE; Desheva JA; Nguyen DC; Rekstin A; Stephenson I; Szretter K; Cox NJ; Rudenko LG; Klimov A; Katz JM Vaccine; 2006 Nov; 24(44-46):6588-93. PubMed ID: 17030078 [TBL] [Abstract][Full Text] [Related]
14. [H5N1: vaccine solutions in men and animals]. Durant MP; Sante; 2006; 16(2):135-8. PubMed ID: 17180763 [No Abstract] [Full Text] [Related]
15. PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Ichinohe T; Ainai A; Tashiro M; Sata T; Hasegawa H Vaccine; 2009 Oct; 27(45):6276-9. PubMed ID: 19840660 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663 [TBL] [Abstract][Full Text] [Related]
18. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Garg S; Hoelscher M; Belser JA; Wang C; Jayashankar L; Guo Z; Durland RH; Katz JM; Sambhara S Clin Vaccine Immunol; 2007 Jul; 14(7):926-8. PubMed ID: 17494637 [TBL] [Abstract][Full Text] [Related]
19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
20. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. Crevar CJ; Ross TM Virol J; 2008 Oct; 5():131. PubMed ID: 18957098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]